December 15, 2025 · Form 4 insider transaction
Grossman Adam S bought 15,000 shares of ADMA Biologics, Inc. at $5.40 per share, a transaction worth $81.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the reporting person and Fidelity Brokerage Services LLC on December 5, 2024, as previously disclosed by the issuer.